Treatment Outcomes of a Multi-Component Mobile Health Smoking Cessation Pilot Intervention for People with Schizophrenia

References

• Andreasen, N. C., Arndt, S., Miller, D., Flaum, M., & Nopoulos, P. (1995). Correlational studies of the scale for the assessment of negative symptoms and the scale for the assessment of positive symptoms: An overview and update. Psychopathology, 28(1), 7–17. https://doi.org/10.1159/000284894
   PubMed Web of Science ®Google Scholar
• Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J. (2010). Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research, 119(1–3), 101–109. https://doi.org/10.1016/j.schres.2010.02.1030
   PubMed Web of Science ®Google Scholar
• Cather, C., Pachas, G., Cieslak, K., & Evins, A. (2017). Achieving smoking cessation in individuals with schizophrenia: Special considerations. CNS Drugs, 31(6), 471–481. https://doi.org/10.1007/s40263-017-0438-8
   PubMed Web of Science ®Google Scholar
• Chapman, S., Ragg, M., & McGeechan, K. (2009). Citation bias in reported smoking prevalence in people with schizophrenia. The Australian and New Zealand Journal of Psychiatry, 43(3), 277–282. https://doi.org/10.1080/00048670802653372
   PubMed Web of Science ®Google Scholar
• de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2–3), 135–157. https://doi.org/10.1016/j.schres.2005.02.010.
   PubMed Web of Science ®Google Scholar
• Desai, H. D., Seabolt, J., & Jann, M. W. (2001). Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective. CNS Drugs, 15(6), 469–494. https://doi.org/10.2165/00023210-200115060-00005
   PubMed Web of Science ®Google Scholar
• Evins, A. E., Cather, C., Culhane, M. A., Birnbaum, A., Horowitz, J., Hsieh, E., Freudenreich, O., Henderson, D. C., Schoenfeld, D. A., Rigotti, N. A., & Goff, D. C. (2007). A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Pharmacology, 27(4), 380–386. https://doi.org/10.1097/01.jcp.0b013e3180ca86fa
   Google Scholar
• Ferron, J. C., Brunette, M. F., Geiger, P., Marsch, L. A., Adachi-Mejia, A. M., & Bartels, S. J. (2017). Mobile phone apps for smoking cessation: Quality and usability among smokers with psychosis. JMIR Human Factors, 4(1), e7. https://doi.org/10.2196/humanfactors.5933
   PubMedGoogle Scholar
• Fiore, M. C., Bailey, W. C., Cohen, S. J., Goldstein, M. G., & Gritz, E. R. (2000). Treating tobacco use and dependence. Clinical practice guideline, treating tobacco use and dependence. Clinical practice guideline, treating tobacco use and dependence. Clinical practice guideline. US Public Health Service Report.
   Google Scholar
• First, M. B., Williams, J. B. W., Karg, R. S., & Spitzer, R. L. (2015). Structured Clinical Interview for DSM-5 (SCID-5 for DSM-5). American Psychiatric Association.
   Google Scholar
• Gallagher, S. M., Penn, P. E., Schindler, E., & Layne, W. (2007). A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs, 39(4), 487–497. https://doi.org/10.1080/02791072.2007.10399888
   PubMed Web of Science ®Google Scholar
• Glimcher, P. W., & Rustichini, A. (2004). Neuroeconomics: The consilience of brain and decision. Science, 306(5695), 447–452. https://doi.org/10.1126/science.1102566
   PubMed Web of Science ®Google Scholar
• Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121. https://doi.org/10.1016/j.ahj.2005.02.007
   PubMed Web of Science ®Google Scholar
• Higgins, S. T., Davis, D. R., & Kurti, A. N. (2017). Financial incentives for reducing smoking and promoting other health-related behavior change in vulnerable populations. Policy Insights from the Behavioral and Brain Sciences, 4(1), 33–40. https://doi.org/10.1177/2372732216683518
   Google Scholar
• Kishi, T., & Iwata, N. (2015). Varenicline for smoking cessation in people with schizophrenia: Systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 265(3), 259–268. https://doi.org/10.1007/s00406-014-0551-3
   PubMed Web of Science ®Google Scholar
• Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., & Reise, S. P. (2013). The Clinical Assessment Interview for Negative Symptoms (CAINS): Final development and validation. The American Journal of Psychiatry, 170(2), 165–172. https://doi.org/10.1176/appi.ajp.2012.12010109
   PubMed Web of Science ®Google Scholar
• McClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2010). Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. American Journal of Public Health, 100(12), 2464–2172. https://doi.org/10.2105/AJPH.2009.188136
   PubMed Web of Science ®Google Scholar
• McFall, M. J., Saxon, A. A., Malte, C. C., Chow, B. D., Bailey, S. P., Baker, G. M., Beckham, J. C., Boardman, K. D., Carmody, T. P., Joseph, A. M., Smith, M. W., Mei-Chiung, S., Ying, L., Lavori, P. W. (2010). Integrating tobacco cessation into mental health care for posttraumatic stress disorder: A randomized controlled trial. JAMA, 304(22), 2485–2493. https://doi.org/10.1001/jama.2010.1769
   PubMed Web of Science ®Google Scholar
• Olfson, M., Gerhard, T., Huang, C., Crystal, S., & Stroup, T. (2015). Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry, 72(12), 1172–1181. https://doi.org/10.1001/jamapsychiatry.2015.1737
   PubMed Web of Science ®Google Scholar
• Potenza, M. N., Sofuoglu, M., Carroll, K. M., & Rounsaville, B. J. (2011). Neuroscience of behavioral and pharmacological treatments for addictions. Neuron, 69(4), 695–712. https://doi.org/10.1016/j.neuron.2011.02.009
   PubMed Web of Science ®Google Scholar
• Romanowich, P., Mintz, J., & Lamb, R. J. (2009). The relationship between self-efficacy and reductions in smoking in a contingency management procedure. Experimental and Clinical Psychopharmacology, 17(3), 139–145. https://doi.org/10.1037/a0015842
   PubMed Web of Science ®Google Scholar
• Tidey, J. W., Rohsenow, D. J., Kaplan, G. B., Swift, R. M., & Reid, N. (2011). Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology, 217(2), 279–287. https://doi.org/10.1007/s00213-011-2282-8
   PubMed Web of Science ®Google Scholar
• Tsoi, D. T., Porwal, M., & Webster, A. C. (2013). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, (2), CD007253. https://doi.org/10.1002/14651858.CD007253.pub3
   Google Scholar
• U.S. Department of Health and Human Services. (2014). The Health Consequences of Smoking —50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services.
   Google Scholar
• Volpp, K. G., Troxel, A. B., Pauly, M. V., Glick, H. A., Puig, A., Asch, D. A., Galvin, R., Zhu, J., Wan, F., DeGuzman, J., Corbett, E., Weiner, J., & Audrain-McGovern, J. (2009). A randomized, controlled trial of financial incentives for smoking cessation. New England Journal of Medicine, 360(7), 699–709. https://doi.org/10.1056/NEJMsa0806819
   PubMed Web of Science ®Google Scholar
• Wilson, S. M., Thompson, A. C., Currence, E. D., Thomas, S. P., Dedert, E. A., Kirby, A. C., Elbogen, E. B., Moore, S. D., Calhoun, P. S., & Beckham, J. C. (2019). Patient-informed treatment development of behavioral smoking cessation for people with schizophrenia. Behavior Therapy, 50(2), 395–409. https://doi.org/10.1016/j.beth.2018.07.004
   PubMed Web of Science ®Google Scholar
• Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., Calhoun, P. S., & Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715. https://doi.org/10.1080/14622200802443569
   PubMed Web of Science ®Google Scholar
• Ziedonis, D., Kosten, T. R., Glazer, W. M., & Frances, R. J. (1994). Nicotine dependence and schizophrenia. Hospital & Community Psychiatric Services, 45(3), 204–206. https://doi.org/10.1176/ps.45.3.204
   PubMedGoogle Scholar